These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31594458)

  • 1. Design of fluorinated sialic acid analog inhibitor to H5 hemagglutinin of H5N1 influenza virus through molecular dynamics simulation study.
    Jeyaram RA; Radha CA; Gromiha MM; Veluraja K
    J Biomol Struct Dyn; 2020 Aug; 38(12):3504-3513. PubMed ID: 31594458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular dynamics simulation studies on influenza A virus H5N1 complexed with sialic acid and fluorinated sialic acid.
    Jeyaram RA; Priyadarzini TRK; Anu Radha C; Siva Shanmugam NR; Ramakrishnan C; Gromiha MM; Veluraja K
    J Biomol Struct Dyn; 2019 Nov; 37(18):4813-4824. PubMed ID: 30686127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N1 neuraminidase of H5N1 avian influenza A virus complexed with sialic acid and zanamivir - A study by molecular docking and molecular dynamics simulation.
    Jeyaram RA; Anu Radha C
    J Biomol Struct Dyn; 2022; 40(21):11434-11447. PubMed ID: 34369311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate Binding by the Second Sialic Acid-Binding Site of Influenza A Virus N1 Neuraminidase Contributes to Enzymatic Activity.
    Du W; Dai M; Li Z; Boons GJ; Peeters B; van Kuppeveld FJM; de Vries E; de Haan CAM
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30089692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamics simulation of the effects of single (S221P) and double (S221P and K216E) mutations in the hemagglutinin protein of influenza A H5N1 virus: a study on host receptor specificity.
    Behera AK; Chandra I; Cherian SS
    J Biomol Struct Dyn; 2016 Sep; 34(9):2054-67. PubMed ID: 26457729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The binding properties of the H5N1 influenza virus neuraminidase as inferred from molecular modeling.
    Raab M; Tvaroška I
    J Mol Model; 2011 Jun; 17(6):1445-56. PubMed ID: 20853123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified Sialic Acids on Mucus and Erythrocytes Inhibit Influenza A Virus Hemagglutinin and Neuraminidase Functions.
    Barnard KN; Alford-Lawrence BK; Buchholz DW; Wasik BR; LaClair JR; Yu H; Honce R; Ruhl S; Pajic P; Daugherity EK; Chen X; Schultz-Cherry SL; Aguilar HC; Varki A; Parrish CR
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32051275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free energy simulations reveal a double mutant avian H5N1 virus hemagglutinin with altered receptor binding specificity.
    Das P; Li J; Royyuru AK; Zhou R
    J Comput Chem; 2009 Aug; 30(11):1654-63. PubMed ID: 19399777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycan binding and specificity of viral influenza neuraminidases by classical molecular dynamics and replica exchange molecular dynamics simulations.
    Phanich J; Threeracheep S; Kungwan N; Rungrotmongkol T; Hannongbua S
    J Biomol Struct Dyn; 2019 Aug; 37(13):3354-3365. PubMed ID: 30126341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newly Emergent Highly Pathogenic H5N9 Subtype Avian Influenza A Virus.
    Yu Y; Wang X; Jin T; Wang H; Si W; Yang H; Wu J; Yan Y; Liu G; Sang X; Wu X; Gao Y; Xia X; Yu X; Pan J; Gao GF; Zhou J
    J Virol; 2015 Sep; 89(17):8806-15. PubMed ID: 26085150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Dual Motif in the Hemagglutinin of H5N1 Goose/Guangdong-Like Highly Pathogenic Avian Influenza Virus Strains Is Conserved from Their Early Evolution and Increases both Membrane Fusion pH and Virulence.
    Wessels U; Abdelwhab EM; Veits J; Hoffmann D; Mamerow S; Stech O; Hellert J; Beer M; Mettenleiter TC; Stech J
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29899102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prime-Boost Vaccination With a Novel Hemagglutinin Protein Produced in Bacteria Induces Neutralizing Antibody Responses Against H5-Subtype Influenza Viruses in Commercial Chickens.
    Sączyńska V; Romanik-Chruścielewska A; Florys K; Cecuda-Adamczewska V; Łukasiewicz N; Sokołowska I; Kęsik-Brodacka M; Płucienniczak G
    Front Immunol; 2019; 10():2006. PubMed ID: 31552018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses.
    Kamlangdee A; Kingstad-Bakke B; Osorio JE
    J Virol; 2016 Aug; 90(15):6771-6783. PubMed ID: 27194759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.
    Boonnak K; Matsuoka Y; Wang W; Suguitan AL; Chen Z; Paskel M; Baz M; Moore I; Jin H; Subbarao K
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter to the editor: Highly pathogenic influenza A(H5N1) viruses in farmed mink outbreak contain a disrupted second sialic acid binding site in neuraminidase, similar to human influenza A viruses.
    de Vries E; de Haan CA
    Euro Surveill; 2023 Feb; 28(7):. PubMed ID: 36795504
    [No Abstract]   [Full Text] [Related]  

  • 17. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
    Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK
    J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccine-induced immunity.
    Hervé PL; Lorin V; Jouvion G; Da Costa B; Escriou N
    Virology; 2015 Dec; 486():134-45. PubMed ID: 26433051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel humanized antibody neutralizes H5N1 influenza virus via two different mechanisms.
    Tan Y; Ng Q; Jia Q; Kwang J; He F
    J Virol; 2015 Apr; 89(7):3712-22. PubMed ID: 25609802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.